This wiki has undergone a migration to Confluence found Here
SubstanceSpecification FHIR Resource Proposal
Revision as of 21:55, 13 September 2017 by Riksmithies (talk | contribs)
Contents
- 1 SubstanceSpecification
- 1.1 Owning work group name
- 1.2 Committee Approval Date:
- 1.3 Contributing or Reviewing Work Groups
- 1.4 FHIR Resource Development Project Insight ID
- 1.5 Scope of coverage
- 1.6 RIM scope
- 1.7 Resource appropriateness
- 1.8 Expected implementations
- 1.9 Content sources
- 1.10 Example Scenarios
- 1.11 Resource Relationships
- 1.12 Timelines
- 1.13 gForge Users
- 1.14 When Resource Proposal Is Complete
- 1.15 FMG Notes
SubstanceSpecification
Owning work group name
Committee Approval Date:
13th September 2017
Contributing or Reviewing Work Groups
- Pharmacy
- O&O
FHIR Resource Development Project Insight ID
1338
Scope of coverage
copy from PSS
To support the content of the revised ISO 11238 IDMP Substance standard and its ISO/TS 19844 Technical Specification, and other domain areas with similar requirements. Initial focus to be on the 'Chemical' type (substance and specified substance parts) of that standard and draft resources will be produced to explore the use of FHIR for this. If successful, future scope may be expanded to other areas, and bring the work forward for formal inclusion in the FHIR draft standard.
Scope should consider numerous aspects of breadth of scope, including:
- Subject: Human vs. non-human vs. non-patient (e.g. lab bench medicine)
- Disciplines: Environmental Health, Palliative, Respiratory, Psychology, Maternity, Clinical Research
- Delivery environment (Community, Geriatric, Home care, Emergency, Inpatient, Intensive, Neonatal, Pediatric, Primary)
- Locale: Country, region
As a rule, resources should encompass all of these aspects.
-->
RIM scope
Resource appropriateness
Expected implementations
Content sources
Example Scenarios
Resource Relationships
Timelines
gForge Users
When Resource Proposal Is Complete
When you have completed your proposal, please send an email to FMGcontact@HL7.org